Last updated on March 2017

Efficacy of Ferric Carboxymaltose (Ferinject ) in Anemic Patients Anticipating Pancreatoduodenectomy

Brief description of study

This phase II study is to evaluate the safety and efficacy of Ferinject® in reducing perioperative transfusion in iron deficiency anemia patients anticipating pancreatoduodenectomy.

Detailed Study Description

Primary objectives : Perioperative transfusion rate (including preop, intraop, postop≦7 days). Secondary objectives : Postoperative complication, hospital stay, change of hematological parameters (Hb, ferritin, transferrin saturation (TSAT) change after Ferinject® injection), adverse effect with Ferinject® injection.

Clinical Study Identifier: NCT02628860

Contact Investigators or Research Sites near you

Start Over

Sang Jae Park, MD

National Cancer Center
Goyang, Korea, Republic of
  Connect »